Claraphi Advisory Network, LLC Gsk PLC Transaction History

Claraphi Advisory Network, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$37.87 - $43.58 $17,041 - $19,611	-450 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$32.47 - $48.83 $220,796 - $332,044	-6,800 Reduced 93.79%	450 $17,000
Q4 2019 Feb 13, 2020	SELL	$42.0 - $48.25 $12,600 - $14,475	-300 Reduced 3.97%	7,250 $341,000
Q3 2019 Nov 08, 2019	SELL	$40.46 - $43.52 $10,560 - $11,358	-261 Reduced 3.34%	7,550 $322,000
Q2 2019 Jul 29, 2019	BUY	$39.4 - $42.7 $28,013 - $30,359	711 Added 10.01%	7,811 $313,000
Q3 2018 Nov 09, 2018	SELL	$39.75 - $42.69 $163,491 - $175,583	-4,113 Reduced 36.68%	7,100 $285,000
Q2 2018 Aug 14, 2018	BUY	$39.61 - $42.76 $150,993 - $163,001	3,812 Added 51.51%	11,213 $452,000
Q1 2018 May 14, 2018	SELL	$36.18 - $40.15 $1,809 - $2,007	-50 Reduced 0.67%	7,401 $289,000
Q4 2017 Feb 05, 2018	BUY	$35.34 - $41.9 $263,318 - $312,196	7,451	7,451 $264,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Claraphi Advisory Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Claraphi Advisory Network, LLC with notifications on news.